Jessa Hospital Campus Virga Jesse
Hasselt, Limburg, 3500, Belgium
Location status: Recruiting
NCT Number: NCT07256340
Critically ill patients, such as those with trauma or sepsis, experience high rates of malnutrition (up to 75%). Malnutrition worsens outcomes by increasing infection rates, hospital stays, mortality, and healthcare costs. Adequate nutrition is therefore crucial in the ICU. To ensure appropriate nutrition, accurate determination of total energy expenditure (TEE) is essential. In practice, predictive equations are often used, but these can misestimate TEE in ICU patients due to complex metabolic changes. Indirect calorimetry is recommended but limited by technical constraints. Consequently, the doubly labeled water (DLW) method, though expensive, offers a precise and non-invasive way to measure TEE over time.
This study applies the DLW method in ICU patients to improve energy assessment and guide personalized nutrition strategies that support recovery and outcomes.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Hasselt, Limburg, 3500, Belgium
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Measuring TEE in IC patients with DLW
Time frame: Min: 1-5 days; Max: 1-20 days
Measured using the DLW method by only taking urine samples
Interested in participating?
Request InfoMaastricht University Medical Center
Other
Acronym: IC-TEE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07173855
Arrhythmias, Cardiac, Atrial Fibrillation
Ajax, Ontario, Canada
View Trial DetailsNCT07839949
Critical Illness, Disease Attributes
Palma de Mallorca, Balearic Islands, Spain
View Trial DetailsNCT07837128
Critical Illness, Disease Attributes
Amsterdam, NL, Netherlands
View Trial DetailsNCT07680816
Critical Illness, Disease Attributes
Wuhan, Outside of the US, China
View Trial Details